Results saw all 24 healthy volunteers who made it to the 72-week mark still had effective levels of dMAb in their systems.

Endometriosis is a chronic condition in which tissue similar to the uterine lining grows outside the uterus. Credit: crystal light via Shutterstock. The National Health Service (NHS) in England has ...

Subjects in the fourth cohort will receive a dose nearly 50% higher than the previous cohort. Credit: Amnaj Khetsamtip/Shutterstock. The Safety Review Committee (SRC) has granted unanimous approval ...

CHD is said to occur due to HDV, leading to cirrhosis and liver failure. Credit: Pixel-Shot/Shutterstock. Vir Biotechnology has enrolled the first subject in the Phase III ECLIPSE registrational ...

Amgen’s Uplizna (inebilizumab-cdon) has shown sustained efficacy in a group of gMG patients after 52 weeks in a Phase III ...

The company’s Phase IIb trial found the therapy, N6LS, was able to maintain viral loads below a detectable threshold.

Merck & Co (MSD) is looking to file for approval of its human immunodeficiency virus (HIV) treatment after two positive Phase III trial readouts. Its once-daily oral combination of the approved drug ...

The company’s weight loss therapy was able to sustain itself for up to 40 days in obese patients after a single injection.

The trial aims to evaluate the drug’s pharmacodynamics, tolerability, pharmacokinetics and safety in health participants. Credit: dee karen / Shutterstock. US-based biotechnology company Seismic ...

Antibody-mediated rejection is a significant cause of kidney transplant failure. Credit: sasirin pamai / Shutterstock. US-based biotechnology company Biogen has begun dosing in the Phase III TRANSCEND ...

Gilead presented the data at the Conference on Retroviruses and Opportunistic Infections (CROI 2025). Image credit: Shutterstock / Sundry Photography Gilead is set to launch a Phase III trial of its ...